A micro-cap tech stock backed by profitable growth
One of these opportunities is little-known Gatekeeper Systems (TSXV:GSI), market cap C$63.90 million, a smart video and data technology stock focused on transportation services, including school buses and public transit, equipping them with cameras, mobile data collectors and AI-enabled software to optimize both passenger safety and service efficiency.
The company, founded in 2013, has built a three-year track record of profitable growth backed by fundamentals supporting long-term value creation. Here are the numbers: Revenue growth of 119.4 per cent from C$17.23 million in 2021 to C$37.81 million in 2024, followed by a respectable over C$13 million collected in 2025 through Q2.
Positive net income in four out of the past five years, including C$1.88 million in 2022, C$2.81 million in 2023 and C$1.99 million in 2024. Though the company has posted a net loss over the first two quarters of 2025, its transit contract win rate is steadily increasing, as detailed in its Q2 2025 news release.
In terms of market share, these figures translate into more than 200,000 video devices and 57,000 mobile data collectors installed to date across all modes of transportation, spanning 60 transit customers, customers in every North American state and province, and about 25 per cent of the North American school district market, with more than 3,500 districts on the Gatekeeper platform.
From this position of strength, and with a transit market tailwind at its back (slide 11), Gatekeeper is focused on closing numerous contracts in its pipeline and parlaying major contract wins – including the Toronto Transit Commission and the Southeastern Pennsylvania Transportation Authority (slide 12) – into further growth supported by recent investments in sales, engineering and legal.
The broader market has shown conviction in the company's growth plan, lifting Gatekeeper Systems stock (TSXV:GSI) by 195.65 per cent since 2020, almost tripling the TSX's return over the period. Shares last traded at C$0.68.
Join the discussion: Find out what everybody's saying about this micro-cap tech stock on the Gatekeeper Systems Inc. Bullboard and check out Stockhouse's stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Canada News.Net
38 minutes ago
- Canada News.Net
Birkenstock, Bugaboo, Coach thrive as rich Americans absorb hikes
LONDON, U.K.: For now, America's wealthier consumers appear unfazed by price increases on high-end products, from Birkenstock sandals to Bugaboo strollers, even as tariffs and economic uncertainty push brands to raise prices. German footwear brand Birkenstock has seen "tremendously strong" demand since introducing higher prices on July 1 to offset U.S. import tariffs, CEO Oliver Reichert told analysts this week. "We saw no pushback or cancellations," he said. The resilience mirrors trends across several premium brands. Bugaboo, the Dutch maker of strollers, high chairs, and playpens retailing for more than US$1,000, raised prices by $50 to $300 in May. "In general, we did not see any pushback," said Jeanelle Teves, Bugaboo's chief commercial officer for North America, noting retailers were "open and accepting" of the changes. Coach handbags have also remained popular, with parent company Tapestry reporting 4.6 million new North American customers this year, many from Gen Z and millennial demographics. CEO Joanne Kuvoiserat said the brand expects to maintain profit margins despite tariff pressures. Ralph Lauren likewise raised its annual revenue forecast as shoppers snapped up items like its $398 Polo Bear sweaters. However, CEO Patrice Louvet cautioned that price sensitivity in the second half remains a key unknown. Bank of America data supports the picture of steady luxury spending. The bank reported that middle—and upper-income cardholders spent more in July than a year earlier, even as spending by lower-income customers stayed flat. The bank noted that lower-income households account for only 15 percent of U.S. consumer spending, meaning overall demand could remain strong if higher-income spending holds up. However, some signs of caution are emerging. Procter & Gamble, maker of Tide detergent, noted that even wealthier consumers are becoming more selective in their purchases. Bugaboo manufactures in China and sells through retailers including Target, Nordstrom, and Bloomingdale's, as well as smaller independent stores. Coach's popular Tabby shoulder bag sells for $350, while Ralph Lauren's luxury apparel continues to command high prices. As brands watch the second half of the year unfold, the big question remains whether affluent shoppers will keep absorbing price hikes or begin to pull back in the face of a "broader pricing environment," Louvet said.
Global News
39 minutes ago
- Global News
She's Got Next: Founders rally in Vancouver behind historic firsts in women's sports
Rogers Arena was host to a first on Friday night: the WNBA's inaugural regular-season game in Vancouver. Before tip-off, inside a private pre-game gathering, She's Got Next founders Julie Smulders and Jill Tracy brought together a powerhouse group of athletes, executives and community leaders to underline a message – Canada is entering a new era for women's sports, and it's time to show up. Smulders, a UBC Thunderbirds alumna who played professional basketball overseas, said the idea for She's Got Next began last year after she and Tracy left a sold-out NCAA women's Final Four and compared it to the Canada West championships in B.C., which drew just 500 fans. 'We thought, 'We can do something in Canada. Let's elevate women's sports. Let's bring a community of women together,' Smulders said. The private event drew some of the most influential figures in Canadian and North American sport: Toronto Tempo president Teresa Resch and general manager Monica Wright Rogers, NBA Canada communications director Ashton Lawrence, PWHL Vancouver general manager Cara Morey and director of business operations Tania Richards, and five-time Olympian and Canadian Olympic Committee president Charmaine Crooks. Story continues below advertisement 5:57 WNBA players call for pay equity Tempo also used the evening to announce that when their inaugural WNBA season tips off next year, two of their regular-season games will be played in B.C., marking another historic milestone for Canadian women's basketball. Instead of hosting galas, She's Got Next has built its brand around what Smulders calls 'games over galas.' The group organizes dedicated fan sections at women's sporting events, including Section 107 at PWHL Vancouver home games. Get daily National news Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy That means when members join the organization, they don't just attend events—they show up in the stands together. 'It's about modelling behaviour,' Tracy said. 'Men have done it for decades—grabbing friends and going to games. We're making that the norm for women's sports.' This season also marks the arrival of PWHL Vancouver, the province's first professional women's hockey franchise. The league has already drawn record-setting attendance in Toronto, Ottawa and Montreal, and now Vancouver fans have a team of their own. Story continues below advertisement 23:49 WNBA in Canada: Teresa Resch hopes Toronto Tempo will 'inspire an entire new generation' Smulders and Tracy said they were emotional seeing young girls in jerseys at PWHL games earlier this year. 'There were no dry eyes in our group when the women took the ice and heard the national anthem,' Tracy recalled. 'We hadn't seen that before.' The fight for visibility in women's sports has been ongoing for a long time. For decades, women were excluded outright: in the U.K., women's soccer was banned for 50 years. In North America, women were often dismissed as 'unable' or 'unfit' to play. 'That mindset doesn't disappear overnight,' Smulders said. In Canada, progress has accelerated in recent years. Christine Sinclair became the world's all-time leading international goal scorer, cementing women's soccer as a national passion. Marie-Philip Poulin's overtime heroics turned her into 'Captain Clutch,' rewriting hockey history. Story continues below advertisement And now, Canadian broadcasters are carrying more women's games—including, for the first time this year, all Indiana Fever WNBA games featuring star rookie Caitlin Clark. 'If you don't see it, you don't believe it's possible,' Smulders said. 'Now kids across Canada are seeing it.' 1:57 'To be brave, and to be bold': WNBA empowering next generation Smulders remembered her UBC days when the women's basketball team was fed Subway while the men's team got steak dinners. 'We were grateful just to get anything,' she said. Today's generation isn't settling. 'They want jerseys in their size. They want visibility. They want equality,' Tracy said. 'To them, women are just athletes. Period.' For Smulders and Tracy, the message to fans, institutions and media is clear: women's sports are not a novelty, they are the future. Story continues below advertisement Alongside fan sections and events, She's Got Next is launching scholarships for student-athletes, building career pipelines for women graduating from university sport, and continuing to host pre-game gatherings that unite athletes, executives, coaches, entrepreneurs and fans. The organization also has dedicated fan sections starting with Section 107 at every PWHL Vancouver game. The first WNBA game in Vancouver, the arrival of PWHL hockey in B.C., and the coming Northern Super League aren't just milestones; they're an invitation. The question now is whether Canadians will keep showing up, not just for history, but for what comes next. 'Come to games. Become members. Tell your friends,' Smulders urged. Tracy added: 'The bigger the community, the bigger our impact.'
Cision Canada
2 days ago
- Cision Canada
ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering
SASKATOON, SK, Aug. 15, 2025 /CNW/ - ZYUS Life Sciences Corporation (the " Company") (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that, further to its press release dated July 29, 2025, it has closed the second tranche (the " Second Tranche") of its non-brokered private placement (the " Offering") of units of the Company (each a " Unit") for up to CAD $1,000,000. Under the Second Tranche of the Offering, a further 140,845 Units were issued for aggregate gross proceeds of CAD $100,000. The aggregate gross proceeds raised in the Second Tranche and first tranche of the Offering (which closed on July 29, 2025) (the " First Tranche") is approximately $0.42 million. The Company has issued a total of 591,126 Units each priced at $0.71 per Unit in the First Tranche and the Second Tranche. Each Unit consists of one common share of the Company (a " Common Share") and one Common Share purchase warrant (each Common Share purchase warrant, a " Warrant"), whereby each Warrant entitles the holder to acquire one Common Share at a price of $0.95 for a period of twenty-four months from the date of issuance, unless the term of the Warrant is accelerated pursuant to its terms (the " Acceleration Provision"). In accordance with the Acceleration Provision, if the volume-weighted average trading price of the Common Shares is greater than $3.00 for a period of 5 consecutive trading days on the TSX Venture Exchange (the " TSXV"), the Company will have the right to accelerate the expiry date of the Warrants. Proceeds of the Offering will be used for general corporate and working capital purposes. No finder's fees were paid in connection with the Offering. The Units were offered by way of private placement pursuant to exemptions from prospectus requirements under applicable securities laws. All securities issued under the First Tranche are subject to a hold period expiring November 30, 2025, and all securities issued under the Second Tranche of the Offering are subject to a hold period expiring December 16, 2025, in accordance with applicable securities laws and the policies of the TSXV. The Offering has received conditional approval from the TSXV and remains subject to final acceptance of the TSXV. The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the " U.S. Securities Act"), or any state securities laws, and may not be offered or sold within the United States or to, or for account or benefit of, U.S. persons except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to available exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any securities in the United States. About ZYUS Life Sciences Corporation ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS' unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients' lives. For additional information, visit or follow us on X @ZYUSCorp. Cautionary Note Regarding Forward-Looking Statements This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, receipt of TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering. Any such forward-looking statements may be identified by words such as "expects", "anticipates", "intends", "contemplates", "believes", "projects", "plans", "will" and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, obtain TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the Company will be able to achieve these results. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances or actual results unless required by applicable law. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.
